Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries

by Tomasz Bochenek, Vafa Abilova, Ali Alkan, Bogdan Asanin, Iñigo de Miguel Beriain, Zeljka Besovic, Patricia Vella Bonanno, Anna Bucsics, Michal Davidescu, Elfi De Weerdt, Natasa Duborija-Kovacevic, Jurij Fürst, Mina Gaga, Elma Gailīte, Jolanta Gulbinovič, Jolanta Gulbinovič, Emre U. Gürpınar, Balázs Hankó, Vincent Hargaden, Tor A. Hotvedt, Iris Hoxha, Isabelle Huys, Andras Inotai, Andras Inotai, Arianit Jakupi, Helena Jenzer, Helena Jenzer, Roberta Joppi, Ott Laius, Marie-Camille Lenormand, Despina Makridaki, Despina Makridaki, Admir Malaj, Kertu Margus, Vanda Marković-Peković, Vanda Marković-Peković, Nenad Miljković, João L. de Miranda, João L. de Miranda, Stanislav Primožič, Dragana Rajinac, David G. Schwartz, Robin Šebesta, Steven Simoens, Juraj Slaby, Ljiljana Sović-Brkičić, Tomas Tesar, Leonidas Tzimis, Ewa Warmińska, Brian Godman, Brian Godman, Brian Godman
Published 2018-01-01

Generic Medicine Pricing Policies in Europe: Current Status and Impact

by Pieter Dylst, Steven Simoens
Published 2010-03-01

Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians

by Liese Barbier, Yannick Vandenplas, Steven Simoens, Paul Declerck, Arnold G. Vulto, Isabelle Huys
Published 2021-06-01

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

by Brian Godman, Brian Godman, Brian Godman, Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Antony P. Martin, Steven Simoens, Amanj Kurdi, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso Guerra, Augusto Alfonso Guerra, Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Björn Wettermark, Zinhle Matsebula, Stephen Campbell, Stephen Campbell, Alan Haycox
Published 2018-12-01

Health Economics of Antibiotics

by Steven Simoens
Published 2010-04-01

Informing Patients about Biosimilar Medicines: The Role of European Patient Associations

by Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto, Isabelle Huys
Published 2021-02-01

Development and implementation of “Check of Medication Appropriateness” (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance

by Charlotte Quintens, Thomas De Rijdt, Tine Van Nieuwenhuyse, Steven Simoens, Willy E. Peetermans, Bart Van den Bosch, Minne Casteels, Isabel Spriet
Published 2019-02-01

Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis

by Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto, Arnold G. Vulto, Isabelle Huys
Published 2021-04-01

Insights into European drug shortages: a survey of hospital pharmacists.

by Kim Pauwels, Steven Simoens, Minne Casteels, Isabelle Huys
Published 2015-01-01

Biosimilar medicines and cost-effectiveness

by Steven Simoens
Published 2011-02-01

How to Value Orphan Drugs? A Review of European Value Assessment Frameworks

by Alessandra Blonda, Yvonne Denier, Isabelle Huys, Steven Simoens
Published 2021-05-01

Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US

by Chiara Whichello, Eline van Overbeeke, Rosanne Janssens, Karin Schölin Bywall, Selena Russo, Jorien Veldwijk, Irina Cleemput, Juhaeri Juhaeri, Bennett Levitan, Jürgen Kübler, Meredith Smith, Richard Hermann, Matthias Englbrecht, Axel J. Hueber, Alina Comanescu, Sarah Harding, Steven Simoens, Isabelle Huys, Esther W. de Bekker-Grob
Published 2019-09-01

Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review

by Rosanne Janssens, Isabelle Huys, Eline van Overbeeke, Chiara Whichello, Sarah Harding, Jürgen Kübler, Juhaeri Juhaeri, Antonio Ciaglia, Steven Simoens, Hilde Stevens, Meredith Smith, Bennett Levitan, Irina Cleemput, Esther de Bekker-Grob, Jorien Veldwijk
Published 2019-10-01

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation

by Patricia Vella Bonanno, Michael Ermisch, Brian Godman, Brian Godman, Brian Godman, Antony P. Martin, Jesper Van Den Bergh, Liudmila Bezmelnitsyna, Anna Bucsics, Francis Arickx, Alexander Bybau, Tomasz Bochenek, Marc van de Casteele, Eduardo Diogene, Irene Eriksson, Irene Eriksson, Jurij Fürst, Mohamed Gad, Ieva Greičiūtė-Kuprijanov, Martin van der Graaff, Jolanta Gulbinovic, Jolanta Gulbinovic, Jan Jones, Roberta Joppi, Marija Kalaba, Ott Laius, Irene Langner, Ileana Mardare, Vanda Markovic-Pekovic, Vanda Markovic-Pekovic, Einar Magnusson, Oyvind Melien, Dmitry O. Meshkov, Guenka I. Petrova, Gisbert Selke, Catherine Sermet, Steven Simoens, Ad Schuurman, Ricardo Ramos, Jorge Rodrigues, Corinne Zara, Eva Zebedin-Brandl, Alan Haycox
Published 2017-08-01

Payers’ views of the changes arising through the possible adoption of Adaptive Pathways

by Michael Ermisch, Anna Bucsics, Patricia Vella Bonanno, Francis Arickx, Alexander Bybau, Tomasz Bochenek, Marc Van De Casteele, Eduardo Diogene, Jurij Furst, Kristina Garuoliene, Kristina Garuoliene, Martin van der Graaff, Jolanta Gulbinovic, Jolanta Gulbinovic, Alan Haycox, Jan Jones, Roberta Joppi, Ott Laius, Irene Langner, Anthony Martin, Vanda Markovic-Pekovic, Vanda Markovic-Pekovic, Laura McCullagh, Einar Magnusson, Ellen Nilsen, Gisbert Selke, Catherine Sermet, Steven Simoens, Robert Sauermann, Ad Schuurman, Ricardo Ramos, Vera Vlahovic-Palcevski, Corinne Zara, Brian Godman, Brian Godman
Published 2016-09-01

From generic to biosimilar drugs: why take an innovative pace?

by Fereshteh Barei, Claude Le Pen, Steven Simoens
Published 2012-12-01

Off-label use of orphan medicinal products: a Belgian qualitative study

by Marc Dooms, David Cassiman, Steven Simoens
Published 2016-10-01

Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries

by Ewa Stawowczyk, Krzysztof Piotr Malinowski, Paweł Kawalec, Rafał Bobiński, Jacek Siwiec, Dimitra Panteli, Dimitra Panteli, Dimitra Panteli, Helene Eckhardt, Helene Eckhardt, Helene Eckhardt, Steven Simoens, Antònia Agusti, Antònia Agusti, Marc Dooms, Andrzej Pilc, Andrzej Pilc
Published 2019-11-01

Introduction and utilisation of high priced HCV medicines across Europe; implications for the future

by Winnie de Bruijn, Cristina Ibáñez, Pia Frisk, Hanne Bak Pedersen, Ali Alkan, Patricia Vella Bonanno, Ljiljana Sović Brkičić, Anna Bucsics, Guillame Dedet, Jaran Eriksen, Joseph O Fadare, Jurij Fürst, Gisselle Gallego, Isabella Piassi Godói, Isabella Piassi Godói, Augusto Afonso Guerra Junior, Augusto Afonso Guerra Junior, Hakki Gürsöz, Saira Jan, Saira Jan, Jan Jones, Saim Kerman, Roberta Joppi, Ott Laius, Newman Madzikwa, Einar Magnusson, Mojca Maticic, Vanda Markovic-Pekovic, Vanda Markovic-Pekovic, Amos Massele, Olayinka Ogunleye, Olayinka Ogunleye, Aisling O’Leary, Jutta Piessnegger, Catherine Sermet, Steven Simoens, Celda Tiroyakgosi, Ilse Truter, Magnus Thyberg, Kristina Tomekova, Magdalene Wladysiuk, Sortiris Vandoros, Elif Hilal Vural, Corinne Zara, Brian Godman, Brian Godman
Published 2016-07-01

Cost-Utility Analysis of Lipegfilgrastim Compared to Pegfilgrastim for the Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Stage II-IV Breast Cancer

by Esse I. H. Akpo, Irshaad R. Jansen, Edith Maes, Steven Simoens
Published 2017-09-01